Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Chinese Clinical Oncology|April 6, 2015
Stage II colon cancerDavid N Church, Rachel Midgley, David J KerrNature Clinical Practice. Oncology|October 22, 2008
Capecitabine: have we got the dose right?Rachel Midgley, David J KerrNature Clinical Practice. Oncology|August 4, 2005
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!Rachel Midgley, David J KerrActa Oncologica (Stockholm, Sweden)|August 6, 2003
Colorectal cancerShibani Nicum, Rachel Midgley, David J KerrSeminars in Oncology|May 25, 2010
Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liverThinn P Pwint, Rachel Midgley, David J KerrJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.Cancer Journal (Sudbury, Mass.)|June 8, 2010
Gene profiling in early stage diseaseRachel Midgley, Kakil Rasul, Haitham Al Salama, et al.Ebiomedicine|September 3, 2021
Automated assessment of CD8<sup>+</sup> T-lymphocytes and stroma fractions complement conventional staging of colorectal cancerDan Jiang, Tarjei S Hveem, Mark Glaire, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Bevacizumab--current status and future directionsRachel Midgley, David KerrScientific Reports|March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent mannerMark B Wiley, Jessica Bauer, Valentina Alvarez, et al.Pageof 16